These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

800 related items for PubMed ID: 21080348

  • 21. Long-term outcomes with multi-targeted immunosuppressive protocol in children with severe proliferative lupus nephritis.
    Aragon E, Resontoc LP, Chan YH, Lau YW, Tan PH, Loh HL, Ng KH, Yap HK.
    Lupus; 2016 Apr; 25(4):399-406. PubMed ID: 26537422
    [Abstract] [Full Text] [Related]

  • 22. Serum levels of autoantibodies against C-reactive protein correlate with renal disease activity and response to therapy in lupus nephritis.
    Sjöwall C, Zickert A, Skogh T, Wetterö J, Gunnarsson I.
    Arthritis Res Ther; 2009 Apr; 11(6):R188. PubMed ID: 20003354
    [Abstract] [Full Text] [Related]

  • 23. Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the Lupus Nephritis Assessment with Rituximab study.
    Rovin BH, Furie R, Latinis K, Looney RJ, Fervenza FC, Sanchez-Guerrero J, Maciuca R, Zhang D, Garg JP, Brunetta P, Appel G, LUNAR Investigator Group.
    Arthritis Rheum; 2012 Apr; 64(4):1215-26. PubMed ID: 22231479
    [Abstract] [Full Text] [Related]

  • 24. Is mycophenolate mofetil superior to pulse intravenous cyclophosphamide for induction therapy of proliferative lupus nephritis in Egyptian patients?
    El-Shafey EM, Abdou SH, Shareef MM.
    Clin Exp Nephrol; 2010 Jun; 14(3):214-21. PubMed ID: 20169461
    [Abstract] [Full Text] [Related]

  • 25. [Mycophenolate mofetil maintenance therapy in lupus nephritis].
    Milewski M, Jakieła B, Zółciński M, Chmielewska A, Musiał J.
    Pol Arch Med Wewn; 2006 Oct; 116(4):947-54. PubMed ID: 18416296
    [Abstract] [Full Text] [Related]

  • 26. Distinct effects of mycophenolate mofetil and cyclophosphamide on renal fibrosis in NZBWF1/J mice.
    Yung S, Zhang Q, Chau MK, Chan TM.
    Autoimmunity; 2015 Oct; 48(7):471-87. PubMed ID: 26099989
    [Abstract] [Full Text] [Related]

  • 27. Mycophenolate mofetil or tacrolimus compared with intravenous cyclophosphamide in the induction treatment for active lupus nephritis.
    Li X, Ren H, Zhang Q, Zhang W, Wu X, Xu Y, Shen P, Chen N.
    Nephrol Dial Transplant; 2012 Apr; 27(4):1467-72. PubMed ID: 21917733
    [Abstract] [Full Text] [Related]

  • 28. Combined low-dose mycophenolate mofetil and tacrolimus for lupus nephritis with suboptimal response to standard therapy: a 12-month prospective study.
    Mok CC, To CH, Yu KL, Ho LY.
    Lupus; 2013 Oct; 22(11):1135-41. PubMed ID: 23995863
    [Abstract] [Full Text] [Related]

  • 29. Relative efficacy and safety of tacrolimus, mycophenolate mofetil, and cyclophosphamide as induction therapy for lupus nephritis: a Bayesian network meta-analysis of randomized controlled trials.
    Lee YH, Song GG.
    Lupus; 2015 Dec; 24(14):1520-8. PubMed ID: 26162684
    [Abstract] [Full Text] [Related]

  • 30. Mycophenolate mofetil treatment of severe renal disease in pediatric onset systemic lupus erythematosus.
    Buratti S, Szer IS, Spencer CH, Bartosh S, Reiff A.
    J Rheumatol; 2001 Sep; 28(9):2103-8. PubMed ID: 11550982
    [Abstract] [Full Text] [Related]

  • 31. Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis.
    Ginzler EM, Dooley MA, Aranow C, Kim MY, Buyon J, Merrill JT, Petri M, Gilkeson GS, Wallace DJ, Weisman MH, Appel GB.
    N Engl J Med; 2005 Nov 24; 353(21):2219-28. PubMed ID: 16306519
    [Abstract] [Full Text] [Related]

  • 32. The effects of cyclophosphamide and mycophenolate on end-stage renal disease and death of lupus nephritis.
    Koo HS, Kim YC, Lee SW, Kim DK, Oh KH, Joo KW, Kim YS, Ahn C, Han JS, Kim S, Chin HJ.
    Lupus; 2011 Nov 24; 20(13):1442-9. PubMed ID: 21951944
    [Abstract] [Full Text] [Related]

  • 33. Rituximab vs mycophenolate and vs cyclophosphamide pulses for induction therapy of active lupus nephritis: a clinical observational study.
    Moroni G, Raffiotta F, Trezzi B, Giglio E, Mezzina N, Del Papa N, Meroni P, Messa P, Sinico AR.
    Rheumatology (Oxford); 2014 Sep 24; 53(9):1570-7. PubMed ID: 24505125
    [Abstract] [Full Text] [Related]

  • 34. Morphological Indexes: Can They Predict Lupus Nephritis Outcomes? A Retrospective Study.
    Navarro D, Ferreira AC, Viana H, Carvalho F, Nolasco F.
    Acta Med Port; 2019 Oct 01; 32(10):635-640. PubMed ID: 31625875
    [Abstract] [Full Text] [Related]

  • 35. [Manifestation of diffuse proliferative lupus nephritis in a patient treated with long-term mycophenolate mofetil].
    Sixdorf U, Bauer H, Märker-Hermann E.
    Dtsch Med Wochenschr; 2006 Oct 13; 131(41):2266-9. PubMed ID: 17036267
    [Abstract] [Full Text] [Related]

  • 36. A randomized pilot trial comparing cyclosporine and azathioprine for maintenance therapy in diffuse lupus nephritis over four years.
    Moroni G, Doria A, Mosca M, Alberighi OD, Ferraccioli G, Todesco S, Manno C, Altieri P, Ferrara R, Greco S, Ponticelli C.
    Clin J Am Soc Nephrol; 2006 Sep 13; 1(5):925-32. PubMed ID: 17699309
    [Abstract] [Full Text] [Related]

  • 37. Mycophenolate mofetil as the primary treatment of membranous lupus nephritis with and without concurrent proliferative disease: a retrospective study of 29 cases.
    Kasitanon N, Petri M, Haas M, Magder LS, Fine DM.
    Lupus; 2008 Jan 13; 17(1):40-5. PubMed ID: 18089682
    [Abstract] [Full Text] [Related]

  • 38. Kidney Outcomes and Risk Factors for Nephritis (Flare/De Novo) in a Multiethnic Cohort of Pregnant Patients with Lupus.
    Buyon JP, Kim MY, Guerra MM, Lu S, Reeves E, Petri M, Laskin CA, Lockshin MD, Sammaritano LR, Branch DW, Porter TF, Sawitzke A, Merrill JT, Stephenson MD, Cohn E, Salmon JE.
    Clin J Am Soc Nephrol; 2017 Jun 07; 12(6):940-946. PubMed ID: 28400421
    [Abstract] [Full Text] [Related]

  • 39. Combination of anti-SSA/Ro60 and anti-dsDNA serotype is predictive of belimumab renal response in patients with lupus nephritis.
    Zhao L, Wang W, Wu L, Wu T, Tu J, Wu X, Sun F, Ding H, Shen N, Wu H, Zhu J, Sun L, Ye S.
    Lupus Sci Med; 2024 May 28; 11(1):. PubMed ID: 38806217
    [Abstract] [Full Text] [Related]

  • 40. Combination therapy of mycophenolate mofetil and tacrolimus in lupus nephritis.
    Lanata CM, Mahmood T, Fine DM, Petri M.
    Lupus; 2010 Jul 28; 19(8):935-40. PubMed ID: 20388722
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 40.